
IntelePeer and SOAP Health Announce Strategic Partnership to Leap Forward Healthcare Efficiency and Patient Outcomes
'Together with SOAP Health, we're empowering healthcare organizations to transform operations and reimagine care delivery. Built on IntelePeer's AI-powered platform, the entirety of administrative and clinical needs across the patient journey are addressed with best-in-class conversational AI and analytics solutions for healthcare,' said Frank Fawzi, Chief Executive Officer at IntelePeer. 'By integrating SOAP's AI-driven clinical workflows with our platform, we deliver end-to-end solutions that enhance both administrative efficiency and clinical effectiveness—from registration and scheduling to diagnosis and documentation.'
'ClinicalAI is the future of patient medical practice,' added Dr. Steven Charlap, Chief Executive Officer of SOAP Health. 'With IntelePeer, we're delivering a zero-friction, voice-first experience that drives efficiency, accuracy, and revenue.'
Addressing the Pressures of Modern Healthcare
Medical practices today face mounting challenges—rising no-show rates, revenue cycle inefficiencies, staffing shortages, and increasing patient expectations. Together, IntelePeer and SOAP Health offer a powerful solution that:
Automates voice, SMS, and omnichannel workflows driving 75% self-serve patient interactions
Saves time and reduces burnout by up to 12 minutes per patient
Improves patient outcomes: ClinicalAI surfaces hidden clinical insights
Delivers enterprise-wide insights: SmartAnalytics offers real-time workflow visibility
SOAP Health's ClinicalAI conducts natural-language interviews via voice or text, capturing over 300 structured data points—including family history and social determinants of health—before the patient even enters the exam room. This data is synthesized into a Smart SOAP Note for the practitioner.
IntelePeer's SmartAgent then automates the entire patient journey—from appointment scheduling and intake to care coordination and follow-up—while SmartAnalytics delivers real-time operational and clinical insights.
With proven results across diverse care settings, the IntelePeer and SOAP Health partnership marks a pivotal step toward a more intelligent, efficient, and patient-centered healthcare system.
About IntelePeer
IntelePeer streamlines customer interactions, enabling businesses and contact centers to lower costs, improve customer experience, and accelerate return on investment. Harnessing the power of agentic AI, IntelePeer's Conversational AI Platform delivers speed, observability, visibility, and flexibility — all built on top of a global, secure communications network. Producing human-like interactions, the platform automates voice and digital customer service capabilities and provides industry-leading time-to-value with solutions that work seamlessly with existing enterprise software and infrastructure, and easy-to-use tools that can be utilized by anyone.
To learn more about IntelePeer, visit: www.intelepeer.ai.
About SOAP Health
SOAP Health offers the AI-First Primary Care model, an end-to-end clinical solution that covers everything from patient intake to note integration into the EMR. Save time, improve risk assessments and diagnostic accuracy, and generate more revenue. SOAP's AI Smarts. Physicians Experience. An Unbeatable Combination.
To learn more about SOAP Health, visit https://soap.health.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
29 minutes ago
- Yahoo
DOGE has built an AI tool to slash federal regulations
The Department of Government Efficiency hopes to use a new AI tool to eliminate half of the federal government's regulatory mandates, according to The Washington Post. Citing a PowerPoint presentation dated July 1, The Post reports that the DOGE AI Deregulation Decision Tool is supposed to analyze around 200,000 federal regulations and identify the ones that are no longer required by law, with the goal of eliminating half those regulations by the first anniversary of President Donald Trump's return to office. It seems this work is already underway, with the presentation declaring the tool has already been used to review regulations at the Department of Housing and Urban Development and to write '100% of deregulations' Consumer Financial Protection Bureau. A White House spokesperson told The Post that 'no single plan has been approved or greenlit' but praised the DOGE team as 'the best and brightest in the business.' This is just the latest AI tool developed by DOGE (led in the early months of the Trump administration by Elon Musk), including one reportedly error-prone tool that would hallucinate the size of Veterans Affairs contracts. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
29 minutes ago
- Yahoo
Why Morgan Stanley Thinks Alphabet's (GOOGL) Innovation Cycle Isn't Priced In Yet
Alphabet Inc. (NASDAQ:GOOGL) is one of the . On July 24, Morgan Stanley reiterated the stock as 'Overweight' and raised its price target to $210 per share from $205 following Alphabet's latest earnings report on Wednesday. Analyst Brian Nowak is optimistic about Google's accelerating cloud revenue growth and its updated AI-based engagement metrics. 'Search, YouTube and Google Cloud all accelerated as GenAI-enabled innovation is driving faster growth,' he wrote in a Thursday note to clients. 'Our EPS ests are largely unchanged (revenue higher offset by higher D & A/investment) but we remain OW as this accelerated pace of innovation sets up GOOGL for more durable multi-year growth.' A business person pointing to a graph displaying a company's projected EBITDA growth. Alphabet Inc. (NASDAQ:GOOGL) is an American multinational technology conglomerate holding company wholly owning the internet giant Google, amongst other businesses. While we acknowledge the potential of GOOGL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure: None. Sign in to access your portfolio
Yahoo
29 minutes ago
- Yahoo
Meta Sees Ad Momentum Ahead of Earnings — Analysts Raise Targets
Meta Platforms, Inc. (NASDAQ:META) is one of the . On July 23, Benchmark analyst Mark Zgutowicz raised the firm's price target on the stock to $800 from $640 and kept a 'Buy' rating on the shares. Discussing the Q2 results and guidance due on July 30, the firm said that it anticipates 'stable top-line' results on the back of steady ecommerce trends and sustained US and Canada ad pricing leverage. The firm said that Meta has witnessed acceleration in these markets for the past two consecutive quarters, and believes that revenue per advertiser will increase from Advantage+ attribution enhancements implemented in May. The analysts further stated that Zuckerberg's recent pledge of 'hundreds of billions of dollars' in AI infrastructure, coupled with its AI research hire,s will 'certainly be topical on its 2Q earnings call.' As such, it anticipates the company's 2025 capex guidance to be maintained while opex guidance to be 'tightened a bit higher.' While we acknowledge the potential of META as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure: None. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data